What Is an Angioma? Types, Causes, Symptoms, & Treatment

An angioma is a benign growth made up of blood vessels or lymphatic vessels. The term is broad and somewhat loosely applied in medicine, covering everything from the tiny red dots that appear on your skin in middle age to clusters of abnormal blood vessels deep inside the brain. Because “angioma” is an umbrella label rather than a single diagnosis, the type matters enormously: a cherry angioma on your chest is a cosmetic concern at most, while a cavernous angioma in the brainstem can cause seizures or hemorrhage. Understanding which kind you are dealing with is the first step toward knowing whether it needs treatment at all.

Why the Word “Angioma” Covers So Many Things

Historically, almost any clump of abnormal blood vessels got called an angioma or hemangioma, regardless of whether it was a true tumor (cells actively dividing) or a structural malformation (vessels that formed abnormally during development but are not growing on their own). That distinction matters clinically. True hemangiomas, like the ones seen in infants, are benign tumors of endothelial cells that proliferate rapidly and then usually shrink on their own over several years. Vascular malformations, by contrast, are errors of blood vessel development present from birth that grow along with the child and never spontaneously resolve.

Modern classification systems have tried to sort out this confusion, but the older terminology persists in everyday clinical use and on radiology reports. You will still see “cavernous angioma” for a brain lesion that is technically a cavernous malformation, or “venous angioma” for what specialists now call a developmental venous anomaly. In practical terms, the most common angiomas people encounter fall into a handful of categories: cherry angiomas, spider angiomas, infantile hemangiomas, and cerebral cavernous malformations.

Cherry Angiomas

Cherry angiomas are the small, bright red or purple bumps that start popping up on your torso, arms, and sometimes face beginning in your thirties or forties. They are the single most common type of angioma, and nearly everyone develops at least a few with age. They range from pinpoint size to several millimeters across, feel smooth or slightly raised, and bleed easily if scratched or nicked but are otherwise painless. Under a dermatoscope they show a characteristic pattern of red clods or lacunae.

A population-based study of older adults found that cherry angiomas were more common in women than men and that having many of them correlated with lower blood-sugar markers and, in women, with higher levels of HDL cholesterol and lower triglycerides.

That does not mean cherry angiomas are a sign of good health exactly, but it does mean their presence is not a red flag for any serious disease. They are benign, they do not become cancerous, and they do not require removal unless they bother you cosmetically or bleed repeatedly from their location.

What Causes Cherry Angiomas at the Genetic Level

For a long time, cherry angiomas were considered so unremarkable that nobody looked very hard at what drives them. That changed when researchers started sequencing their DNA. A study of 85 cherry angioma samples found a high frequency of mutations in a family of genes called GNA14, GNAQ, and GNA11. These genes encode signaling proteins that sit inside cells and relay growth signals. When mutated, they activate pathways that promote cell growth and survival, which leads to the small proliferation of blood vessel cells that forms the angioma.

An earlier, smaller study confirmed this pattern, identifying somatic mutations in GNAQ and GNA11 in half of the cherry angiomas tested. These same mutation hotspots show up in other vascular growths, including port-wine stains and congenital hemangiomas, which suggests a shared molecular mechanism across different types of angiomas despite their very different clinical behavior.

⁴

Removing Cherry Angiomas

Because cherry angiomas are harmless, treatment is optional and cosmetic. The two most common in-office procedures are cryotherapy (freezing with liquid nitrogen) and electrosurgery (using an electric current to destroy the tissue). A blinded randomized trial comparing the two approaches found that electrosurgery produced higher satisfaction scores among both patients and physicians for cherry angiomas.

⁵

Pulsed dye laser is another option that targets the red pigment in blood and can treat the angioma without damaging surrounding skin. All three approaches are quick outpatient procedures with minimal downtime.

Spider Angiomas and Liver Disease

Spider angiomas look different from cherry angiomas. They have a central red dot (the feeding arteriole) with thin, radiating blood vessel branches that resemble spider legs. Pressing on the center briefly blanches the whole lesion, which refills from the center outward when you release. A few spider angiomas are perfectly normal and can appear in healthy people, especially during pregnancy when estrogen levels are high. But when multiple spider angiomas appear, particularly on the upper body and face, they raise concern about liver disease.

In patients with liver cirrhosis, about a third develop spider angiomas. A study of 82 cirrhotic patients found that those with spider angiomas had higher bilirubin levels, longer clotting times, and a higher prevalence of alcoholism. Alcohol use and bilirubin level were the two strongest independent predictors of whether a cirrhotic patient would develop them.

⁶

Research into the underlying mechanism has pointed to a signaling molecule called substance P. Cirrhotic patients with spider angiomas had roughly double the plasma levels of substance P compared to those without, and in statistical modeling, substance P was the only independent predictor of spider angiomas in that study, with a threefold increase in odds.

⁷

Substance P is a peptide normally cleared by the liver, so when liver function deteriorates, it accumulates and promotes the dilation and proliferation of small blood vessels in the skin.

Spider angiomas themselves do not need treatment for medical reasons, but if you develop several new ones and have not been evaluated for liver problems, it is worth bringing up with your doctor. When the underlying liver disease is managed, spider angiomas sometimes fade on their own.

Infantile Hemangiomas

Infantile hemangiomas are the most common tumors of infancy, appearing in the first few weeks of life as flat red marks or raised strawberry-colored lumps. They grow rapidly during the first several months (the proliferative phase), then gradually shrink over years (the involuting phase). Most resolve without intervention by school age, though larger or more complex ones can leave behind loose skin, scarring, or residual blood vessels.

The overwhelming majority are medically harmless, but location matters. A hemangioma near the eye can obstruct vision and trigger amblyopia. One on the lip or airway can interfere with feeding or breathing. In those cases, treatment with oral propranolol (a beta-blocker) has become the standard approach, dramatically shrinking the tumor and reducing complications. For uncomplicated hemangiomas, watchful waiting is the norm.

The psychosocial dimension is real even when the hemangioma is medically benign. Parents often report strong feelings of disbelief and panic during the growth phase, and children with visible hemangiomas who did not receive treatment show lower social initiative and greater anxiety in new situations compared to those who were treated.

⁸

That finding reinforces why early referral to a specialist can matter even for lesions that would eventually resolve on their own.

⁹

Cerebral Cavernous Malformations

Cerebral cavernous malformations (CCMs), also called cavernous angiomas or cavernomas, are clusters of tightly packed, abnormally thin-walled blood vessels in the brain or spinal cord. They look like mulberries on MRI, with a dark ring of hemosiderin (iron deposits from old micro-bleeds) surrounding the lesion. Unlike cherry angiomas on the skin, these are not trivial: they can cause seizures, headaches, focal neurological deficits, and hemorrhage.

Structurally, the walls of CCMs lack normal supporting tissue. Electron microscopy studies have shown ruptures and damage in the lining of the blood vessels, gaps between the endothelium and the underlying basement membrane, and shrunken or deformed support cells called pericytes.

¹⁰

These structural weaknesses are what make CCMs prone to leaking blood into surrounding brain tissue.

Despite the frightening name, the hemorrhage rate is relatively low. A retrospective study tracking CCM patients over time found an annual bleed rate of about 1% per lesion-year. However, that rate was not uniform: lesions that had already bled were over five times more likely to bleed again, and those located in functionally important areas of the brain also carried higher risk.

¹¹

Many people with CCMs live their entire lives without symptoms and only discover the lesion incidentally on brain imaging done for another reason.

How Cerebral Cavernous Malformations Are Found

MRI is the gold standard for detecting CCMs, but not all MRI sequences are equally sensitive. A specialized technique called susceptibility-weighted imaging (SWI) detects significantly more lesions than conventional sequences because it is particularly good at picking up the small iron deposits and blood products that surround these malformations.

¹²

This is especially important in familial forms of CCM, where patients tend to have multiple lesions scattered throughout the brain and conventional MRI may undercount them. Despite its advantages, SWI is still not included in every standard brain MRI protocol, so if you or your doctor suspect CCMs, it is worth requesting that the sequence be added.

¹³

Treatment of Cerebral Cavernous Malformations

For CCMs that have not caused symptoms, observation with periodic MRI is usually the first-line approach. For lesions that have bled or caused seizures, surgical removal is the most definitive treatment when the lesion is in an accessible location. When surgery is too risky because of the lesion’s location, Gamma Knife radiosurgery has shown promise as an alternative. A study of CCM patients who underwent Gamma Knife treatment found that it decreased the risk of hemorrhage in those who had previously experienced symptomatic bleeding.

¹⁴

An exciting line of research involves propranolol, the same beta-blocker used to treat infantile hemangiomas. A phase 2 pilot trial in patients with familial CCMs found that those taking propranolol alongside standard care had a lower incidence of symptomatic hemorrhage or new neurological deficits compared to those receiving standard care alone. The trial was not large enough to confirm efficacy definitively, but it showed a signal strong enough to warrant larger studies.

¹⁵

The rationale for trying propranolol came from its success with infantile hemangiomas, which share certain pathological features with cavernous malformations.

¹⁶

Developmental Venous Anomalies

If you have ever gotten a brain MRI and been told you have a “venous angioma,” you likely have what is now called a developmental venous anomaly (DVA). These are the most frequently encountered vascular malformations in the brain and are considered extreme variations of normal venous anatomy rather than true malformations. A DVA looks on imaging like a cluster of small veins draining into a single larger collecting vein, sometimes described as a “caput medusae” or Medusa head pattern.

DVAs are overwhelmingly benign and asymptomatic. The problem arises when they coexist with cavernous malformations, which happens fairly often. In those cases, it is typically the cavernous malformation, not the DVA, that is responsible for any hemorrhage or symptoms. Surgeons need to be aware of the DVA because removing it could disrupt the drainage of normal brain tissue, potentially causing a venous infarct. For isolated DVAs without an associated cavernous malformation, no treatment is needed.

¹⁷

Tufted Angiomas and the Importance of Correct Diagnosis

Tufted angiomas are rare, slow-growing vascular tumors that appear as reddish or purplish patches or plaques, usually during childhood. They spread gradually but do not become cancerous. Under the microscope, they consist of small, tightly packed lobules of blood vessel cells scattered through the skin. The reason they matter clinically is that they can look similar under a microscope to more serious conditions. Researchers have stressed the importance of recognizing the distinctive features of tufted angiomas so they are not misdiagnosed as Kaposi’s sarcoma or a low-grade angiosarcoma, both of which require very different management.

¹⁸

In rare cases, tufted angiomas can trigger a serious complication called Kasabach-Merritt phenomenon, where the vascular tumor traps and destroys platelets, leading to dangerous drops in clotting factors. This complication requires urgent treatment and is one reason why a biopsy-confirmed diagnosis matters even for what appears to be a benign vascular growth.

Angiomas in Sturge-Weber Syndrome

Sturge-Weber syndrome is a rare condition that illustrates how angiomas can be part of a broader disease process rather than isolated findings. It involves a port-wine birthmark on the face (a capillary malformation), angiomatosis of the membranes covering the brain, and often glaucoma in the eye on the same side.

¹⁹

The brain angiomas in Sturge-Weber can cause seizures, developmental delays, and progressive neurological problems. The condition is caused by a somatic mutation in the GNAQ gene, the same gene family implicated in cherry angiomas, though the timing and location of the mutation during embryonic development determine whether someone gets a few harmless skin dots or a syndrome affecting the brain and eyes.

Quality of Life and Vascular Malformations

For the visible types of angiomas and vascular malformations, the impact on quality of life can be substantial and is often underappreciated by clinicians who focus on whether the lesion is medically dangerous. A systematic review looking at health-related quality of life in patients with vascular malformations found that facial port-wine stains had a moderate influence on emotional well-being and daily functioning, with emotional distress scores being notably higher than symptom-related scores.

²⁰

This means the lesion does not have to hurt or bleed to affect someone’s life. The appearance itself generates distress, social self-consciousness, and in children, can shape how confidently they engage with peers. Treatment decisions for visible angiomas and vascular malformations increasingly take these psychosocial factors into account alongside purely medical criteria. A port-wine stain that is “not dangerous” may still warrant laser treatment if it is affecting a child’s willingness to participate in school activities or a teenager’s mental health. Dismissing a benign angioma as “nothing to worry about” misses the lived experience of the person who has it.